A randomized, open-label, single-dosing, 2x2 crossover study to compare the safety and
pharmacokinetics of HUG116 tablet(Tenofovir Disoproxil) with Viread® tablet(Tenofovir
Disoproxil Fumarate) in healthy male volunteers
Drug: Viread® tablet 300mg
Drug: HUG116 tablet 245mg
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02902523
Ages eligible for Study
19 Years to 45 Years
Genders eligible for Study
Accepts Healthy Volunteers
Age between 19 to 45, healthy male subjects(at screening)
Body weight over 55kg, in the range of calculated Ideal Body Weight ± 20%
Subject without a hereditary problems, chronic disease and morbid symptom
Volunteer who totally understands the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the progress.
Volunteer who has past or present history of any diseases following below.(liver, kidney,digestive system, pulmonary,hematooncology, endocrine, urinary,neurology,mental disorder, skeletomuscular, immunology, otolaryngology,cardiovascular)
Volunteer who had GI tract disease(Crohn's disease, ulcer, acute or chronic pancreatitis) or surgery(appendectomy, hernioplasty are excluded)
Volunteer who had hypersensitivity reaction to medicines including Tenofovir
Volunteer who has genetic disorders such as glucose-galactose malabsorption, Lapp lactose deficiency, galactose intolerance
Sitting systolic blood pressure > 140mmHg or < 100mmHg, sitting diastolic blood pressure ≥ 90mmHg or < 60mmHg, pulse ≥ 100 beats per minute
Exceed 2 times the normal range of AST, ALT, Total Bilirubin at screening test
Have the result of Creatinine clearance is less than 50mL/min(Cockcroft-Gault equation applicable)
Have the result of serum test(RPR Ab(VDRL), HBsAg, HCV Ab, Anti HIV(AIDS)) is a positive
History of drug abuse, or a positive urine drug screen
Having ETC drug or herbal medicines within 2 weeks before first administration or OTC drug or vitamin preparations within a week before first administration
Participation in any other clinical trial involving investigational drugs within 3 months
Volunteer who had whole blood donation in 2 months, or component blood donation or transfusion in 1 months
Regular alcohol consumption(over 21 units/week, 1unit=10g of pure alcohol) or volunteers who cannot abstain from drinking during the study
Volunteers smoking over 10 cigarettes per day in the last 3 months and taking a surfeit of caffeine(caffeine>400mg per day)
Subjects with planning of dental treatment (tooth extraction, endodontic treatment etc.) and any surgery (aesthetic operation, laser in-situ keratomileusis, laser assisted sub-epithelial keratomileusis etc.) from signed on an informed consent form to post-study visit
Any condition that, in the view of the investigator, would interfere with study participation
Tris trial is registered with FDA with number: NCT02902523. The sponsor of the trial is Huons Co.,Ltd. and it is looking for 50 volunteers for the current phase.
Official trial title:
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.